-
7/29/2019 Daily-equity-report by Epic Research 11.02.13
1/4
-=6HEADLINES
Indian Market
Indian equity markets were down 0.59%
Nifty down by 35.30 pts and settle at5903.50
Sensex down by 114.09 pts at 19466.23
Bank Nifty down by 78.05 pts at12340.00
Global Market
European markets were up with FTSEup by 22.77 closed at 6251 ,CAC up by12.04 closed at 3613 and DAX down by0.03 closed at 7590.
Dow future was down 3.00 closed at
13895.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY
NEWSLETTER11
THFEBRUARY 2013
HEADLINES
M&M Q3 standalone net profit up 26% at
Rs 836cr
Sun Pharma Q3 beats forecast, profit up
32% to Rs 881 cr
Will invite partners for managed services
company: Airtel
Telcos keep removing inactive SIMs;
26m users lost in Dec
-
7/29/2019 Daily-equity-report by Epic Research 11.02.13
2/4
FIIs and DIIs
CATEGORY DATE BUY SELL NET
FII 8-Feb-13 4385.02 2894.2 1490.82
DII 8-Feb-13 953.3 1662.66 -709.36
NIFTY DAILY PIVOTS
IVOT R4 R3 R2 R1 PP S1 S2 S3 S4
IFTY 6123 6053 5983 5943 5913 5873 5843 5773 5703
WWW.EPICRESEARCH.CO 09752199966
MARKETANALYSIS:
Key benchmark indices edged lower in choppy trade on concerns that PSU disinvestment and reductionof promoter stake to meet the Securities & Exchange Board of India (Sebi) mandated minimum publicshareholding of 25% for private companies and 10% for state-run firms will result in supply of equity
in the market over the next few months.BSE Sensex was down 114.09 points or 0.58% to 19,466.23.S&P CNX Nifty was down 44.35 points or 0.75% to 5,894.45.
Among the 30-share Sensex pack, 23 stocks declined while the rest of them rose.Cadila Healthcare fell 2.63% on weak Q3 results. The company's consolidated net profit declined
31.03% to Rs 102.91 crore on 15.67% rise in total income to Rs 1621.17 crore in Q3 December 2012
over Q3 December 2011. Sun Pharmaceutical Industries dropped 0.9% on profit taking after strong Q3results. The stock had witnessed pre-result rally on expectations of strong results. Cement major ACC
declined 3.19%. Ambuja Cements slumped 5.12% IT stocks rose on weak rupee. The rupee droppedfor third session today, 8 February 2013. Infosys gained 0.01%, with the stock reversing intraday
losses.
STOCKS TO WATCH
ALLAHBAD BANK AUROBINDO PHARMA TCS PFC
SCRIPS IN BAN PERIOD
WELCORP
PUNJLYOD
SUZLON
IRB
-
7/29/2019 Daily-equity-report by Epic Research 11.02.13
3/4
WWW.EPICRESEARCH.CO 09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Bearish
Strategy: Sell on rise
Support:5860
Resistance: 5950
BANK NIFTY
Bank Nifty looks Bearish
Strategy: Sell on rise
Support:12280
Resistance:12400
.0
GAINERSANDLOOSERS
PREVIOUSPERFORMANCE
TYPE SCRIP B/S RESULT
CASHALLAHBAD
BANKS SL TRIGERRE
CASHAPOLLO
TYREB TARGET HIT
FUTURETATA
MOTORSS
NOT
EXECUTED
FUTUREARBINDO
PHARMAS TARGET HIT
UPCOMINGRESULTS
BRITANNIA
HEXAWARE
JAIPRAKASHASSOCIATES
TATAPOWER
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
TCS 1422.60 3486.81 1387.15 35.45 2.56
Wipro 412.40 1064.71 405.70 6.70 1.65
BHEL 208.75 3394.24 206.00 2.75 1.33
HDFC
Bank650.05 4706.66 641.50 8.55 1.33
L & T 1511.10 894.21 1496.40 14.70 0.98
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
Ambuja
Cement189.55 6564.25 199.95 -10.4 -5.2
Cipla 380.65 4826.51 394.1 -13.45 -3.41
Hindalco 109.7 15775.97 113.35 -3.65 -3.22
ACC 1303.75 651.48 1344.3 -40.55 -3.02
Sesa Goa 169.85 1613.89 174.4 -4.55 -2.61
-
7/29/2019 Daily-equity-report by Epic Research 11.02.13
4/4
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
ANDHRA BANK SELL 102.00 101.00 99.50 103.00
STERLITE SELL 100.60 99.60 98.10 101.60
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
ALLAHBAD BANK SELL 147.00 146.00 144.50 148.00
AUROBINDO
PHARMA SELL 181.20 180.20 179.20 182.20
DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved.Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.